Arecor Therapeutics
Entity

  • Arecor Therapeutics

    Created in 2007


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    4,205

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Chesterford Research Park, Chesterford research park, Little Chesterford, Saffron Walden CB10 1XL, UK

    Little Chesterford

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 35

  • Engaged catalyst

    3
    0 0

  • Added in Motherbase

    11 months, 1 week ago
Description
  • Value proposition

    Improving health and life for people living with diabetes, obesity and other cardiometabolic diseases

    Arecor is a clinical-stage biotech company, developing superior therapeutics that can reduce treatment burden and improve outcomes for people living with diabetes, obesity and other cardiometabolic diseases.

    Superior Products for Diabetes Treatment, Liquid Products with Superior Stability, Lyo-to-liquid switch, IV to SC switch, High Concentration mAbs, Ready-to-Use (RTU) Formats, Differentiated Biosimilars, Vaccine Stability, and Oral Delivery of Peptides

Catalyst interactions
Catalyst Type Tweets Articles
AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing (Auto)
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing (Auto) 		Other

30 Sep 2025


GSK
GSK
Pharmaceutical, Pharmaceutical Manufacturing (Auto)
GSK
Pharmaceutical, Pharmaceutical Manufacturing (Auto) 		Other

30 Sep 2025


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing (Auto)
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing (Auto) 		Other

30 Sep 2025


Social network dynamics
Similar entities
BETA
Last news
Show all articles